Orchid Pharma inform that Orchid Pharma Limited (“the Company”) has transferred the Formulations business (IKKT) at lrungattukottai, Chennai by way of a stump sale on a going concern basis to M/s. OrBion. Pharmaceuticals Private Limited (“OPPL”) as contemplated in the Business Transfer Agreement ("BTA") dated July 21, 2024.
In This collaboration, Bionpharma Health iNC holds 74% and the Company holds 26% of the equity share capital of M/s. OrBion Pharmaceuticals Private Limited.
In This collaboration, Bionpharma Health iNC holds 74% and the Company holds 26% of the equity share capital of M/s. OrBion Pharmaceuticals Private Limited.